HIGH-TITER HIV-1 NEUTRALIZING ANTIBODY-RESPONSE OF RHESUS MACAQUES TO GP160 AND ENV PEPTIDES

被引:10
作者
RONCO, J
DEDIEU, JF
MARIE, FN
PINTER, A
KACZOREK, M
GIRARD, M
机构
[1] INST PASTEUR,DEPT VIROL,MOLEC VIROL LAB,CNRS,URA 545,28 RUE DOCTEUR ROUX,F-75724 PARIS 15,FRANCE
[2] PASTEUR MERIEUX SERUMS & VACCINS,PARC IND INCARVILLE,F-27101 VAL DE REUIL,FRANCE
[3] PROTEINE PERFORMANCE,F-75018 PARIS,FRANCE
[4] PUBL HLTH RES INST CITY NEW YORK INC,NEW YORK,NY 10016
关键词
D O I
10.1089/aid.1992.8.1117
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Three groups of four rhesus macaques were immunized twice, one month apart with purified recombinant HIV-1LAI gp160 in the presence of either alum, incomplete Freund's adjuvant (IFA), or SAF-1. Two months later, the animals were injected twice again with a synthetic peptide with the sequence of the principal neutralization determinant (PND) of the HIV-1LAI isolate mixed with the same adjuvants. All animals received a booster injection of gp160 and PND peptide at 6 months. This regimen of immunization induced in the SAF-1 and IFA groups a high-titer neutralizing antibody response that declined progressively over the course of the following 6 months. In contrast, only a weak response was observed in the alum group. Neutralizing antibody titers varied as anti-PND titers, suggesting that they were principally targeted to the PND. A shortened immunization protocol comprising two injections of gp160 at 0 and 1 month followed by one injection of PND peptide at 3 months is suggested as optimal for the induction of high titers of HIV-1 neutralizing antibodies in primates.
引用
收藏
页码:1117 / 1123
页数:7
相关论文
共 44 条
[1]   MAJOR GLYCOPROTEIN ANTIGENS THAT INDUCE ANTIBODIES IN AIDS PATIENTS ARE ENCODED BY HTLV-III [J].
ALLAN, JS ;
COLIGAN, JE ;
BARIN, F ;
MCLANE, MF ;
SODROSKI, JG ;
ROSEN, CA ;
HASELTINE, WA ;
LEE, TH ;
ESSEX, M .
SCIENCE, 1985, 228 (4703) :1091-1094
[2]   AN ADJUVANT FORMULATION THAT SELECTIVELY ELICITS THE FORMATION OF ANTIBODIES OF PROTECTIVE ISOTYPES AND OF CELL-MEDIATED-IMMUNITY [J].
ALLISON, AC ;
BYARS, NE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (02) :157-168
[3]   EFFECT OF DOSE AND IMMUNIZATION SCHEDULE ON IMMUNE-RESPONSE OF BABOONS TO RECOMBINANT GLYCOPROTEIN-120 OF HIV-1 [J].
ANDERSON, KP ;
LUCAS, C ;
HANSON, CV ;
LONDE, HF ;
IZU, A ;
GREGORY, T ;
AMMANN, A ;
BERMAN, PW ;
EICHBERG, JW .
JOURNAL OF INFECTIOUS DISEASES, 1989, 160 (06) :960-969
[4]   SEROLOGICAL RESPONSES IN CHIMPANZEES INOCULATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS GLYCOPROTEIN (GP120) SUBUNIT VACCINE [J].
ARTHUR, LO ;
PYLE, SW ;
NARA, PL ;
BESS, JW ;
GONDA, MA ;
KELLIHER, JC ;
GILDEN, RV ;
ROBEY, WG ;
BOLOGNESI, DP ;
GALLO, RC ;
FISCHINGER, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8583-8587
[5]   CHALLENGE OF CHIMPANZEES (PAN-TROGLODYTES) IMMUNIZED WITH HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN-GP120 [J].
ARTHUR, LO ;
BESS, JW ;
WATERS, DJ ;
PYLE, SW ;
KELLIHER, JC ;
NARA, PL ;
KROHN, K ;
ROBEY, WG ;
LANGLOIS, AJ ;
GALLO, RC ;
FISCHINGER, PJ .
JOURNAL OF VIROLOGY, 1989, 63 (12) :5046-5053
[6]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 CHALLENGE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT ENVELOPE GLYCOPROTEIN GP120 [J].
BERMAN, PW ;
GROOPMAN, JE ;
GREGORY, T ;
CLAPHAM, PR ;
WEISS, RA ;
FERRIANI, R ;
RIDDLE, L ;
SHIMASAKI, C ;
LUCAS, C ;
LASKY, LA ;
EICHBERG, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (14) :5200-5204
[7]   PROTECTION OF CHIMPANZEES FROM INFECTION BY HIV-1 AFTER VACCINATION WITH RECOMBINANT GLYCOPROTEIN GP120 BUT NOT GP160 [J].
BERMAN, PW ;
GREGORY, TJ ;
RIDDLE, L ;
NAKAMURA, GR ;
CHAMPE, MA ;
PORTER, JP ;
WURM, FM ;
HERSHBERG, RD ;
COBB, EK ;
EICHBERG, JW .
NATURE, 1990, 345 (6276) :622-625
[8]   MEASUREMENTS OF THE TRUE AFFINITY CONSTANT IN SOLUTION OF ANTIGEN-ANTIBODY COMPLEXES BY ENZYME-LINKED IMMUNOSORBENT-ASSAY [J].
FRIGUET, B ;
CHAFFOTTE, AF ;
DJAVADIOHANIANCE, L ;
GOLDBERG, ME .
JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 77 (02) :305-319
[9]   IMMUNIZATION OF CHIMPANZEES CONFERS PROTECTION AGAINST CHALLENGE WITH HUMAN-IMMUNODEFICIENCY-VIRUS [J].
GIRARD, M ;
KIENY, MP ;
PINTER, A ;
BARRESINOUSSI, F ;
NARA, P ;
KOLBE, H ;
KUSUMI, K ;
CHAPUT, A ;
REINHART, T ;
MUCHMORE, E ;
RONCO, J ;
KACZOREK, M ;
GOMARD, E ;
GLUCKMAN, JC ;
FULTZ, PN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) :542-546
[10]   THE CHALLENGE OF HIV VACCINES [J].
GIRARD, M .
VACCINE, 1991, 9 (11) :781-783